A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in participants with asthma or COPD with type…

Asthma AcuteCOPD Exacerbation Acute

~Estimated

~$10 – $8,750

Connect Biopharm LLCNCT07705737

Phase 4

A Phase 4, Multicenter, Cluster Randomized, Open-label, Intervention Versus Usual Care, Controlled Study on the Effect of Emergency Department Initiation of Airsupra on Asthma Outcomes

The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other rela…

Asthma AcuteAsthma ExacerbationAsthma+1 more

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT07166939